CLASS ACTION UPDATE for GERN, HPQ and BDX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / February 28, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided. There is no cost or obligation to you.

Geron Corporation (NASDAQ:GERN)
GERN Lawsuit on behalf of: investors who purchased March 19, 2018 – September 26, 2018
Lead Plaintiff Deadline: March 23, 2020
Join the action: https://www.zlk.com/pslra-1/geron-corporation-et-al-loss-form?wire=3&prid=5546

The filed complaint alleges that defendants misled investors regarding a drug called imetelstat, which was intended to treat certain cancers that occur in bone marrow. Specifically, defendants misled investors about the results of a clinical drug study of imetelstat called IMbark. That study was designed to ascertain whether imetelstat helped patients with a cancer called myelofibrosis.

To learn more about the Geron Corporation class action, contact jlevi@levikorsinsky.com.

HP Inc. (NYSE:HPQ)
HPQ Lawsuit on behalf of: investors who purchased February 23, 2017 – October 3, 2019
Lead Plaintiff Deadline: April 20, 2020
Join the action: https://www.zlk.com/pslra-1/hp-inc-loss-form?wire=3&prid=5546

According to the filed complaint, defendants knew that HP's "four-box" model for measuring its supplies business was severely deficient and not a strong predictor of supplies demand and outcomes because HP lacked telemetry data from its commercial printers and had to use unreliable and stagnant market share data to develop assumptions for the four-box model. The complaint further alleges that defendants knew the lack of telemetry data for commercial printing was a critical shortcoming of the four-box model because HP possessed telemetry data on its personal printing side and knew it was a necessary element for an accurate understanding of the supplies channel. As a result, the supplies inventory in the Company's channel exceeded demand by at least $100 million and HP's supplies revenue growth was grossly inflated.

To learn more about the HP Inc. class action, contact jlevi@levikorsinsky.com.

Becton Dickinson & Company (NYSE:BDX)
BDX Lawsuit on behalf of: investors who purchased November 5, 2019 – February 5, 2020
Lead Plaintiff Deadline: April 27, 2020
Join the action: https://www.zlk.com/pslra-1/becton-dickinson-company-loss-form?wire=3&prid=5546

The lawsuit alleges: Becton Dickinson & Company made materially false and/or misleading statements throughout the class period and/or failed to disclose that: (1) certain of Becton's Alaris infusion pumps experienced software errors and alarm prioritization issues; (2) as a result, the Company was investing in remediation efforts to address these product issues, rather than a software upgrade to "make enhancements;" (3) the Company was reasonably likely to face regulatory delays in connection with the software remediation; (4) as a result of the foregoing, Becton was reasonably likely to recall certain of its Alaris infusion pumps; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis.

To learn more about the Becton Dickinson & Company class action, contact jlevi@levikorsinsky.com.

You have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 578408